NUE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Given the investor's beginner level, long-term strategy, and available capital, Nucor Corp (NUE) is not a strong buy at this moment. While the company has shown solid financial performance and hedge funds are buying, the technical indicators are neutral to bearish, and recent analyst downgrades suggest limited upside potential in the short term. Additionally, geopolitical risks and insider selling further dampen the near-term outlook.
The MACD is negative and contracting (-2.172), RSI is neutral (26.038), and moving averages are converging, indicating a lack of clear momentum. The stock is trading near its key support level (S1: 174.335) but remains below the pivot (182.999), suggesting potential downside risk.
Hedge funds are significantly increasing their positions in the stock, with a 1257.47% increase in buying over the last quarter.
Strong financial performance in Q4 2025, with revenue up 8.64% YoY and net income up 32.36% YoY.
Stable dividend history with a 1.3% annualized yield.
Insider selling has increased by 514.53% over the last month, signaling potential lack of confidence from management.
Recent analyst downgrades and limited upside in price targets.
Geopolitical risks, including new tariffs and trade tensions, could negatively impact the company's operations and investor sentiment.
In Q4 2025, Nucor reported strong financial growth: Revenue increased by 8.64% YoY to $7.69 billion, net income rose by 32.36% YoY to $378 million, EPS grew by 35.25% YoY to $1.65, and gross margin improved by 26.52% YoY to 11.21%.
Recent analyst activity includes multiple downgrades: UBS downgraded to Neutral with a price target of $183, Morgan Stanley downgraded to Equal Weight with a price target of $180, and Wells Fargo lowered its price target to $176. However, Jefferies and JPMorgan maintain Buy/Overweight ratings with higher price targets of $190 and $200, respectively.
